99m^Tc-MIBI显像诊断肿瘤的价值
被引量：1
摘要
MIBI的全称为methoxyisobutylisonitrile,也称sestamibi,中文全称'甲氧基异丁基异腈',也称'甲氧异腈'.99mTc-MIBI(以下均简称MIBI)最初为心肌显像剂,自从发现其能被肿瘤组织摄取以来,其诊断肿瘤的价值得到了广泛和深入地研究,现总结如下:
出处
《中国实用医刊》
2010年第1期52-54,共3页
Chinese Journal of Practical Medicine
同被引文献15
-
1Spyridonidis TJ, Matsouka P, Symeonidis A, et al. Tc-99m Sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma [J]. Clin Nucl Med, 2013,38 ( 11 ) : 847-854.
-
2Zelenetz AD, Wierda WG, Abramson JS, et al. Non-Hodgkin's Lymphomas, version 3.2012 [J]. Journal of the National Comprehensive Cancer Network, 2012,10(12) : 1487-1498.
-
3Cunningham D, I-Iawkes EA, Jack A, et al. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non- Hodgkin lymphoma : a phase 3 comparison of dose intensification with 14-day versus 21-day cycles [J]. Lancet, 2013,381 (9880) : 1817-1826.
-
4Shih WJ, Rastogi A, Stipp V, et al. Functional retention of Tc- 99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging [J]. Clin Nucl Med, 1998, 23(8) : 505-508.
-
5Martelli M, Ceriani L, Zucca E, et al. [18F]fluorodeoxyglueose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study [J ]. J Clin Oncol, 2014,32 (17) : 1769-1775.
-
6Song HC, Lee JJ, Bom HS, et al. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non- Hodgkin' s lymphoma [ J ]. Clin Nucl Med, 2003,28 (6) : 457- 462.
-
7Ladetto M, Lobetti-Bodoni C, Mantoan B, et al. Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program [J]. Blood, 2013,122(23) :3759-3766.
-
8Hendrikse NH, Franssen EJF, van der Graaf WTA, et al. l'c- sestamibi is a substrate for P-glyeoprotein and the multidrug resistance-associated protein [ J] Br J Cancer, 1998,77 (3), 353-358.
-
9Sulicka J, Surdacki A, Mikolajczyk T, et al. Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemia [ J 1. Immunobiology, 2013,218 (5) : 810-816.
-
10Rokugawa T, Uehara T, Higaki Y, et al. Potential of 9'q'c-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice [J]. EJNMMI Research, 2014,4 : 57.
引证文献1
-
1陆智祥,江勇,余大富,米岚,迟昆萍,王凡,吕梁,吴晓群,孙鹥.非霍奇金淋巴瘤化疗后^(99m)Tc-MIBI显像的价值[J].实用医学杂志,2015,31(22):3732-3735. 被引量：4
二级引证文献4
-
1张若,刘玉婷,金刚.^(99)Tc^m-MIBI SPECT/CT同机融合显像在肿瘤诊断中的临床价值[J].标记免疫分析与临床,2017,24(10):1193-1196. 被引量：7
-
2江生,黄志顺,劳雪芳,龚义洪.探讨SPECT/CT同机图像融合技术对于乳腺肿瘤显像及判断淋巴结转移与骨转移的临床应用价值[J].现代诊断与治疗,2019,30(6):853-856. 被引量：5
-
3江生,黄志顺,肖国有.99Tc^m-MIBI乳腺亲肿瘤显像对乳腺癌的诊断价值分析[J].中国医学装备,2021,18(1):63-67. 被引量：2
-
4李卫鹏,李辉,胡永全,陶新全,申勇,孙景秋,袁超.应用^(99)Tc^(m)-MIBI纳米粒子SPECT-CT显像评价乳腺癌对新辅助化疗的耐药性试验研究初探[J].中华全科医学,2024,22(5):764-767.
-
1陈勇,王长生,侯治河,侯庆田,王信辉.^(99m)TC-MIBI心肌断层显像潘生丁试验103例分析[J].邯郸医学高等专科学校学报,2000,13(4):316-317.
-
2陈敏山.活检：有利有弊，因病而异[J].中国家庭医生,2005(07S):46-46.
-
3周国良,李昭骥,林伟,叶广春,魏学立.高血压患者^(99m)TC MIBI心肌单光子发射计算机断层显像改变[J].广州医学院学报,1992(4):24-27.
-
4朱绍莉,袁颖,孔宪胜,张燕燕,刘蕴忠,李家秀,王铁.心肌显像剂^(99m)Tc-TBIⅡ期临床试验[J].北京大学学报（医学版）,1989,31(S1):43-45. 被引量：1
-
5李皖生.用探针治疗脑肿瘤[J].国外医学情报,1995(21):13-13.
-
6叶军,凌月蓉,游宇光.多普勒超声显像诊断胎儿脐带绕颈[J].赣南医学院学报,1993(2):62-63.
-
7朱绍莉,袁颖,孔宪胜.心肌显像剂^(99m)Tc-TBI的Ⅰ期临床试验[J].北京大学学报（医学版）,1989,31(S1):45-48.
-
8许文清.恶性肿瘤特异性生长因子检测诊断肿瘤的应用[J].临床和实验医学杂志,2006,5(6):676-677. 被引量：5
-
9徐荷芳.4206例舌下脉的观察分析[J].浙江中西医结合杂志,1992,2(3). 被引量：1
